[1]
Alexis, A., Anders, K., Seetasith, A. and Holden, M. 2024. Comparison of Study Designs for Primary Phase III Trials for Omalizumab Versus Dupilumab for Patients With Chronic Spontaneous Urticaria. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s333. DOI:https://doi.org/10.25251/skin.8.supp.333.